1-3 of 3
Leslie B. Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bcl-2/Bcl-xL Inhibition Increases the Efficacy of MEK Inhibition Alone and in Combination with PI3 Kinase Inhibition in Lung and Pancreatic Tumor Models

Nguyen Tan, Maureen Wong, Michelle A. Nannini, Rebecca Hong, Leslie B. Lee, Stephen Price, Karen Williams, Pierre Pascal Savy, Peng Yue, Deepak Sampath, Jeffrey Settleman, Wayne J. Fairbrother, Lisa D. Belmont
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2013) 12 (6): 853–864.
https://doi.org/10.1158/1535-7163.MCT-12-0949
Published: 09 June 2013
View article titled, Bcl-2/Bcl-x<sub>L</sub> Inhibition Increases the Efficacy of MEK Inhibition Alone and in Combination with PI3 Kinase Inhibition in Lung and Pancreatic Tumor Models
Open the PDF for Bcl-2/Bcl-x<sub>L</sub> Inhibition Increases the Efficacy of MEK Inhibition Alone and in Combination with PI3 Kinase Inhibition in Lung and Pancreatic Tumor Models in another window
Includes: Supplementary data
Journal Articles

Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer

Tinya J. Abrams, Lesley J. Murray, Enrico Pesenti, Vicky Walker Holway, Tina Colombo, Leslie B. Lee, Julie M. Cherrington, Nancy K. Pryer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (10): 1011–1021.
Published: 24 October 2003
View article titled, Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer
Open the PDF for Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with “standard of care” therapeutic agents for the treatment of breast cancer in another window
Journal Articles

SU11248 Inhibits KIT and Platelet-derived Growth Factor Receptor β in Preclinical Models of Human Small Cell Lung Cancer

Tinya J. Abrams, Leslie B. Lee, Lesley J. Murray, Nancy K. Pryer, Julie M. Cherrington
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (5): 471–478.
Published: 01 May 2003
View article titled, SU11248 Inhibits KIT and Platelet-derived Growth Factor Receptor β in Preclinical Models of Human Small Cell Lung Cancer
Open the PDF for SU11248 Inhibits KIT and Platelet-derived Growth Factor Receptor β in Preclinical Models of Human Small Cell Lung Cancer in another window